Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
Seal Finger - Clarification
Stanley C Deresinski
Diagnostic Microbiology and Infectious Disease
|
April 4, 2008
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials
Stanley C Deresinski
Diagnostic Microbiology and Infectious Disease
|
April 4, 2008
Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class
Stanley C Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 4, 2025
Aztreonam-ceftazidime-avibactam may not be enough
Niaz Banaei, Stanley C Deresinski
F1000 Medicine Reports
|
October 16, 2010
Management of infections due to KPC-producing Klebsiella pneumoniae
Stanley C Deresinski, Patricia Schirmer
Expert Review of Anti-Infective Therapy
|
September 9, 2009
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections
Patricia L Schirmer, Stanley C Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 27, 2003
Caspofungin
Stanley C Deresinski, David A Stevens
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 5, 2024
Society of Critical Care Medicine/Infectious Diseases Society of America (SCCM/IDSA) New Fever Guideline
Stanley C Deresinski, Naomi P O'Grady
American Journal of Clinical Pathology
|
July 31, 2013
Utility of DNA sequencing for direct identification of invasive fungi from fresh and formalin-fixed specimens
Pablo A Moncada, Indre Budvytiene, Dora Y Ho, et al.
The Journal of Infectious Diseases
|
April 16, 2003
Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial
Carol A Kemper, Richard Haubrich, Ian Frank, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
Seal Finger - Clarification
Stanley C Deresinski
Diagnostic Microbiology and Infectious Disease
|
April 4, 2008
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials
Stanley C Deresinski
Diagnostic Microbiology and Infectious Disease
|
April 4, 2008
Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class
Stanley C Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 4, 2025
Aztreonam-ceftazidime-avibactam may not be enough
Niaz Banaei, Stanley C Deresinski
F1000 Medicine Reports
|
October 16, 2010
Management of infections due to KPC-producing Klebsiella pneumoniae
Stanley C Deresinski, Patricia Schirmer
Expert Review of Anti-Infective Therapy
|
September 9, 2009
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections
Patricia L Schirmer, Stanley C Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 27, 2003
Caspofungin
Stanley C Deresinski, David A Stevens
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 5, 2024
Society of Critical Care Medicine/Infectious Diseases Society of America (SCCM/IDSA) New Fever Guideline
Stanley C Deresinski, Naomi P O'Grady
American Journal of Clinical Pathology
|
July 31, 2013
Utility of DNA sequencing for direct identification of invasive fungi from fresh and formalin-fixed specimens
Pablo A Moncada, Indre Budvytiene, Dora Y Ho, et al.
The Journal of Infectious Diseases
|
April 16, 2003
Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial
Carol A Kemper, Richard Haubrich, Ian Frank, et al.
Page
of 2